Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|23 Mar 2018||Submitted||Original manuscript|
|1 Jun 2018||Reviewed||Reviewer Report - Munya Dimairo|
|4 Jun 2018||Reviewed||Reviewer Report - Matthew Robert Sydes|
|19 Jun 2018||Reviewed||Reviewer Report - William Meurer|
|23 Aug 2018||Author responded||Author comments - Olivier Collignon|
|Resubmission - Version 2|
|23 Aug 2018||Submitted||Manuscript version 2|
|3 Sep 2018||Reviewed||Reviewer Report - Matthew Robert Sydes|
|3 Sep 2018||Reviewed||Reviewer Report - Munya Dimairo|
|1 Oct 2018||Reviewed||Reviewer Report - William Meurer|
|18 Oct 2018||Author responded||Author comments - Olivier Collignon|
|Resubmission - Version 3|
|18 Oct 2018||Submitted||Manuscript version 3|
|21 Oct 2018||Editorially accepted|
|20 Nov 2018||Article published||10.1186/s13063-018-3012-x|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.